Search research articles
Contact Us
Filters
Showing results (111-120 of 122) with videos related to
Page
of 13
Sort By:
Critical Care Medicine
|
October 12, 2020
Acute Kidney Injury in Pediatric Inflammatory Multisystem Syndrome Temporally Associated With Severe Acute Respiratory Syndrome Coronavirus-2 Pandemic: Experience From PICUs Across United Kingdom
Akash Deep, Gaurang Upadhyay, Pascale du Pré, et al.
BMJ Open
|
December 2, 2024
Defining within-host SARS-CoV-2 RNA viral load kinetics during acute COVID-19 infection within different respiratory compartments and their respective associations with host infectiousness: a protocol for a systematic review and meta-analysis
Daniel Pan, Christopher A Martin, Joshua Nazareth, et al.
Plos Medicine
|
May 26, 2022
Risk factors associated with SARS-CoV-2 infection in a multiethnic cohort of United Kingdom healthcare workers (UK-REACH): A cross-sectional analysis
Christopher A Martin, Daniel Pan, Carl Melbourne, et al.
The Lancet Regional Health. Europe
|
October 24, 2024
Immunogenicity of concomitant SARS-CoV-2 and influenza vaccination in UK healthcare workers: a prospective longitudinal observational study
Joshua Nazareth, Christopher A Martin, Daniel Pan, et al.
Eclinicalmedicine
|
April 10, 2023
Ethnic differences in cellular and humoral immune responses to SARS-CoV-2 vaccination in UK healthcare workers: a cross-sectional analysis
Christopher A Martin, Joshua Nazareth, Amar Jarkhi, et al.
Lancet (London, England)
|
December 5, 2021
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial
Alasdair P S Munro, Leila Janani, Victoria Cornelius, et al.
The Lancet. Infectious Diseases
|
May 13, 2022
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial
Alasdair P S Munro, Shuo Feng, Leila Janani, et al.
The Journal of Infection
|
April 13, 2023
Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511]
Xinxue Liu, Alasdair Ps Munro, Shuo Feng, et al.
The Journal of Infection
|
April 11, 2022
Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial
Xinxue Liu, Alasdair P S Munro, Shuo Feng, et al.
The Journal of Infection
|
April 21, 2023
Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial
Xinxue Liu, Alasdair P S Munro, Annie Wright, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 122) with videos related to
Sort By:
Page
of 13
Critical Care Medicine
|
October 12, 2020
Acute Kidney Injury in Pediatric Inflammatory Multisystem Syndrome Temporally Associated With Severe Acute Respiratory Syndrome Coronavirus-2 Pandemic: Experience From PICUs Across United Kingdom
Akash Deep, Gaurang Upadhyay, Pascale du Pré, et al.
BMJ Open
|
December 2, 2024
Defining within-host SARS-CoV-2 RNA viral load kinetics during acute COVID-19 infection within different respiratory compartments and their respective associations with host infectiousness: a protocol for a systematic review and meta-analysis
Daniel Pan, Christopher A Martin, Joshua Nazareth, et al.
Plos Medicine
|
May 26, 2022
Risk factors associated with SARS-CoV-2 infection in a multiethnic cohort of United Kingdom healthcare workers (UK-REACH): A cross-sectional analysis
Christopher A Martin, Daniel Pan, Carl Melbourne, et al.
The Lancet Regional Health. Europe
|
October 24, 2024
Immunogenicity of concomitant SARS-CoV-2 and influenza vaccination in UK healthcare workers: a prospective longitudinal observational study
Joshua Nazareth, Christopher A Martin, Daniel Pan, et al.
Eclinicalmedicine
|
April 10, 2023
Ethnic differences in cellular and humoral immune responses to SARS-CoV-2 vaccination in UK healthcare workers: a cross-sectional analysis
Christopher A Martin, Joshua Nazareth, Amar Jarkhi, et al.
Lancet (London, England)
|
December 5, 2021
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial
Alasdair P S Munro, Leila Janani, Victoria Cornelius, et al.
The Lancet. Infectious Diseases
|
May 13, 2022
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial
Alasdair P S Munro, Shuo Feng, Leila Janani, et al.
The Journal of Infection
|
April 13, 2023
Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511]
Xinxue Liu, Alasdair Ps Munro, Shuo Feng, et al.
The Journal of Infection
|
April 11, 2022
Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial
Xinxue Liu, Alasdair P S Munro, Shuo Feng, et al.
The Journal of Infection
|
April 21, 2023
Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial
Xinxue Liu, Alasdair P S Munro, Annie Wright, et al.
Page
of 13